Our data are in alignment with these findings and suggest that increased tumor expression of TLR4 in STS may therefore represent a mechanism for driving immune cell infiltration, especially cytotoxic lymphocytes, and therapies to target this pathway may prove promising. The gene discussed is TLR4; the disease is neoplasm.